BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 2785587)

  • 1. Economic analysis of clinical positron emission tomography of the heart with rubidium-82.
    Gould KL; Goldstein RA; Mullani NA
    J Nucl Med; 1989 May; 30(5):707-17. PubMed ID: 2785587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical cardiac PET using generator-produced Rb-82: a review.
    Gould KL
    Cardiovasc Intervent Radiol; 1989; 12(5):245-51. PubMed ID: 2514984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography and interventional cardiology.
    Gould KL
    Am J Cardiol; 1990 Oct; 66(14):51F-58F. PubMed ID: 2239702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease.
    Go RT; Marwick TH; MacIntyre WJ; Saha GB; Neumann DR; Underwood DA; Simpfendorfer CC
    J Nucl Med; 1990 Dec; 31(12):1899-905. PubMed ID: 2266384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical cardiac positron emission tomography: state of the art.
    Gould KL
    Circulation; 1991 Sep; 84(3 Suppl):I22-36. PubMed ID: 1884490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82.
    Gould KL; Goldstein RA; Mullani NA; Kirkeeide RL; Wong WH; Tewson TJ; Berridge MS; Bolomey LA; Hartz RK; Smalling RW
    J Am Coll Cardiol; 1986 Apr; 7(4):775-89. PubMed ID: 3485669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic intervention as an alternative to exercise stress.
    Gould KL
    Semin Nucl Med; 1987 Apr; 17(2):121-30. PubMed ID: 3296197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of thallium myocardial scintigraphy (single photon emission computerized tomography, SPECT) for diagnosis of ischemia after myocardial infarct].
    Fries P; Thimme W; Haubold R
    Med Klin (Munich); 1994 Nov; 89(11):582-6. PubMed ID: 7815985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of cardiac patients with negative thallium-201 SPECT and positive rubidium-82 PET myocardial perfusion imaging.
    MacIntyre WJ; Go RT; King JL; Cook SA; Neumann DR; Saha GB; Antar MA
    J Nucl Med; 1993 Mar; 34(3):400-4. PubMed ID: 8441029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac positron emission tomography imaging.
    Machac J
    Semin Nucl Med; 2005 Jan; 35(1):17-36. PubMed ID: 15645392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial myocardial perfusion imaging with dipyridamole and rubidium-82 to assess restenosis after angioplasty.
    Van Tosh A; Garza D; Roberti R; Sherman W; Pompliano J; Ventura B; Horowitz SF
    J Nucl Med; 1995 Sep; 36(9):1553-60. PubMed ID: 7658209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of coronary collaterals in man by PET perfusion imaging.
    Demer LL; Gould KL; Goldstein RA; Kirkeeide RL
    J Nucl Med; 1990 Mar; 31(3):259-70. PubMed ID: 2307996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of myocardial perfusion by positron emission tomography.
    Schwaiger M; Muzik O
    Am J Cardiol; 1991 May; 67(14):35D-43D. PubMed ID: 2035433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management.
    Merhige ME; Breen WJ; Shelton V; Houston T; D'Arcy BJ; Perna AF
    J Nucl Med; 2007 Jul; 48(7):1069-76. PubMed ID: 17607038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine clinical positron emission tomography for diagnostic cardiac imaging--a review.
    Gould KL; Mullani N
    Herz; 1987 Feb; 12(1):13-21. PubMed ID: 3493960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography.
    Herrero P; Markham J; Shelton ME; Bergmann SR
    Circ Res; 1992 Mar; 70(3):496-507. PubMed ID: 1537087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of coronary artery disease in women: roles of three dimensional imaging with magnetic resonance or positron emission tomography.
    Patterson RE; Churchwell KB; Eisner RL
    Am J Card Imaging; 1996 Jan; 10(1):78-88. PubMed ID: 8680137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron imaging of myocardial infarction with rubidium-82.
    Goldstein RA; Mullani NA; Wong WH; Hartz RK; Hicks CH; Fuentes F; Smalling RW; Gould KL
    J Nucl Med; 1986 Dec; 27(12):1824-9. PubMed ID: 3491189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial perfusion with rubidium-82: III. Theory relating severity of coronary stenosis to perfusion deficit.
    Mullani NA
    J Nucl Med; 1984 Nov; 25(11):1190-6. PubMed ID: 6333493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization statistics and diagnostic accuracy of a nonhospital-based positron emission tomography center for the detection of coronary artery disease using rubidium-82.
    Simone GL; Mullani NA; Page DA; Anderson BA
    Am J Physiol Imaging; 1992; 7(3-4):203-9. PubMed ID: 1343217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.